Ujjini H. Manjunatha

Author

Also Known As

Manjunatha, Ujjini, Manjunatha, Ujjini H., U. H. Manjunatha, U.H. Manjunatha, Ujjini H Manjunatha, Ujjini H. Manjunatha, Ujjini Havaldar Manjunatha, Ujjini Manjunatha, Ujjini Manjunatha*, Ujjini H. Manjunatha

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Novartis (Singapore)National Institute of Allergy and Infectious Diseases National Institutes of Health Genomics Institute of the Novartis Research Foundation Novartis (Switzerland)

About

Ujjini H. Manjunatha is an author at Novartis (Singapore) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	2.6K
2	Biochemistry	14	14	1.7K
3	Natural Sciences	13	13	952
4	Health Sciences	3	3	792
5	Engineering	2	2	162

Ujjini H. Manjunatha

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates Laura E. Via, Philana Ling Lin, Sonja M. Ray, Infection and Immunity	2008	644
PA-824 Kills Nonreplicating <i>Mycobacterium tuberculosis</i> by Intracellular NO Release Ramandeep Singh, Ujjini H. Manjunatha, Helena I. Boshoff, Science Bioorganic ChemistryNitric OxideTuberculosis PreventionInnate Immune SystemDrug Resistance	2008	626
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in <i>Mycobacterium tuberculosis</i> Ujjini H. Manjunatha, Helena I. Boshoff, Cynthia S. Dowd, Proceedings of the National Academy of Sciences	2005	328
The mechanism of action of PA-824 Ujjini H. Manjunatha, Helena I. Boshoff, Clifton E. Barry Communicative & Integrative Biology Transcriptional ProfilingNitric Oxide ReleaseMolecular BiologyChemical BiologyRedox Biology	2009	316
A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis Ujjini H. Manjunatha, Sumiti Vinayak, Jennifer A. Zambriski, Nature PharmacologyMedicinePathologyCryptosporidium Pi	2017	191
Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling Siew Pheng Lim, Christian G. Noble, Cheah C. Seh, PLoS Pathogens Viral ReplicationMolecular BiologyAntiviral DrugViral Structural ProteinVirus Structure	2016	174
Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents Suresh B. Lakshminarayana, Tan Bee Huat, Paul C. Ho, Journal of Antimicrobial Chemotherapy	2014	151
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis Srinivasa P. S. Rao, Suresh B. Lakshminarayana, Ravinder Reddy Kondreddi, Science Translational Medicine Tuberculosis PreventionPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceMultidrug-resistant Tuberculosis	2013	149
Evaluating the Sensitivity of Mycobacterium tuberculosis to Biotin Deprivation Using Regulated Gene Expression Sae Woong Park, Marcus Klotzsche, Daniel J. Wilson, PLoS Pathogens Mtb MutantEngineeringMicrobial PathogensTuberculosis PreventionBacteriology	2011	142
Direct inhibitors of InhA are active against <i>Mycobacterium tuberculosis</i> Ujjini H. Manjunatha, Srinivasa P. S. Rao, Ravinder Reddy Kondreddi, Science Translational Medicine	2015	129

Page 1